{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T08:26:05Z","timestamp":1648887965316},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1097\/mnm.0b013e328353b249","type":"journal-article","created":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T06:41:02Z","timestamp":1335854462000},"page":"739-746","source":"Crossref","is-referenced-by-count":1,"title":["Predictors of initial 18F-fluorodeoxyglucose-positron emission tomography indication among patients with colorectal cancer"],"prefix":"10.1097","volume":"33","author":[{"given":"Hanna M.","family":"Zafar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacy","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Bonaccorsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis P.","family":"Langlotz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-9-20210212","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1001\/jama.2010.460","article-title":"Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006.","volume":"303","author":"Dinan","year":"2010","journal-title":"JAMA"},{"key":"R2-9-20210212","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/MLR.0b013e31815dc5ae","article-title":"Utilization trends for advanced imaging procedures: evidence from individuals with private insurance coverage in California.","volume":"46","author":"Mitchell","year":"2008","journal-title":"Med Care"},{"key":"R3-9-20210212","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1148\/radiol.2541090484","article-title":"Resected colorectal cancer among Medicare beneficiaries: adoption of FDG PET.","volume":"254","author":"Zafar","year":"2010","journal-title":"Radiology"},{"key":"R4-9-20210212","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.2967\/jnumed.108.056713","article-title":"Relationship between cancer type and impact of PET and PETCT on intended management: findings of the National Oncologic PET Registry.","volume":"49","author":"Hillner","year":"2008","journal-title":"J Nucl Med"},{"key":"R5-9-20210212","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/cncr.24000","article-title":"The impact of positron emission tomography (PET) on expected management during cancer treatment: findings of the National Oncologic PET Registry.","volume":"115","author":"Hillner","year":"2009","journal-title":"Cancer"},{"key":"R6-9-20210212","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.ejca.2008.05.021","article-title":"Impact of whole-body 18F-FDG PET on diagnostic and therapeutic management of Medical Oncology patients.","volume":"44","author":"Zafra","year":"2008","journal-title":"Eur J Cancer"},{"key":"R7-9-20210212","first-page":"1177","article-title":"A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer.","volume":"41","author":"Huebner","year":"2000","journal-title":"J Nucl Med"},{"key":"R9-9-20210212","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1200\/JCO.2004.12.115","article-title":"Clinical decisions associated with positron emission tomography in a prospective cohort of patients with suspected or known cancer at one United States center.","volume":"22","author":"Hillner","year":"2004","journal-title":"J Clin Oncol"},{"key":"R12-9-20210212","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2407-3-26","article-title":"Follow-up of patients with curatively resected colorectal cancer: a practice guideline.","volume":"3","author":"Figueredo","year":"2003","journal-title":"BMC Cancer"},{"key":"R13-9-20210212","first-page":"1797","article-title":"Direct comparison of (18)F-FDG PET and PETCT in patients with colorectal carcinoma.","volume":"44","author":"Cohade","year":"2003","journal-title":"J Nucl Med"},{"key":"R14-9-20210212","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1053\/ejso.2000.1075","article-title":"Clinical value of whole-body emission tomography in potentially curable colorectal liver metastases.","volume":"27","author":"Topal","year":"2001","journal-title":"Eur J Surg Oncol"},{"key":"R15-9-20210212","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1200\/JCO.2002.20.2.388","article-title":"Value of positron emission tomography with F-18fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study.","volume":"20","author":"Ruers","year":"2002","journal-title":"J Clin Oncol"},{"key":"R16-9-20210212","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/annonc\/mdm108","article-title":"The expanding role of PET technology in the management of patients with colorectal cancer.","volume":"18","author":"Herbertson","year":"2007","journal-title":"Ann Oncol"},{"key":"R17-9-20210212","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/cncr.23823","article-title":"Receipt of guideline-recommended follow-up in older colorectal cancer survivors: a population-based analysis.","volume":"113","author":"Cooper","year":"2008","journal-title":"Cancer"},{"key":"R18-9-20210212","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1067\/mge.2001.118949","article-title":"Bowel surveillance patterns after a diagnosis of colorectal cancer in Medicare beneficiaries.","volume":"54","author":"Knopf","year":"2001","journal-title":"Gastrointest Endosc"},{"key":"R19-9-20210212","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1200\/JCO.2007.14.5631","article-title":"Impact of positron emission tomographycomputed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry.","volume":"26","author":"Hillner","year":"2008","journal-title":"J Clin Oncol"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0b013e328353b249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:42:30Z","timestamp":1620963750000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006231-201207000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0b013e328353b249","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}